Submitted by Anonymous (not verified) on 7 October 2026 - 15:42
Human medicines European public assessment report (EPAR): Nulibry, fosdenopterin, Date of authorisation: 15/09/2022, Revision: 4, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Nulibry, fosdenopterin, Date of authorisation: 15/09/2022, Revision: 4, Status: Authorised